Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2026
Reply to Siddiqui et al., Godbout et al., and to Chang and MaoGeoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Immunotherapy|January 9, 2025
Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumabDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
Current data on biologics: Evaluating clinical remission in asthmaIan Pavord, Rohit K Katial, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 22, 2026
Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort studyAlexandra M Nanzer, Jodie Lam, Cris Roxas, et al.
The Lancet. Respiratory Medicine|July 11, 2025
Eosinophils in asthma phenotypes: perpetrators or guilty by association?Marek Lommatzsch, Roland Buhl, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|March 17, 2015
The influence of asthma control on the severity of virus-induced asthma exacerbationsDavid J Jackson, Maria-Belen Trujillo-Torralbo, Jerico del-Rosario, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
A critical look at the lexicon, parameters, and limitations of asthma remission definitionsDavid J Jackson, Praveen Akuthota, Flavia Cecilia Lega Hoyte, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 21, 2021
Biologics in severe asthma: Which one, When and Where?Hitasha Rupani, Anna Murphy, Katie Bluer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2019
Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1Yanira Riffo-Vasquez, Varsha Kanabar, Sandra D Keir, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2026
Reply to Siddiqui et al., Godbout et al., and to Chang and MaoGeoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Immunotherapy|January 9, 2025
Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumabDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
Current data on biologics: Evaluating clinical remission in asthmaIan Pavord, Rohit K Katial, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 22, 2026
Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort studyAlexandra M Nanzer, Jodie Lam, Cris Roxas, et al.
The Lancet. Respiratory Medicine|July 11, 2025
Eosinophils in asthma phenotypes: perpetrators or guilty by association?Marek Lommatzsch, Roland Buhl, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|March 17, 2015
The influence of asthma control on the severity of virus-induced asthma exacerbationsDavid J Jackson, Maria-Belen Trujillo-Torralbo, Jerico del-Rosario, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
A critical look at the lexicon, parameters, and limitations of asthma remission definitionsDavid J Jackson, Praveen Akuthota, Flavia Cecilia Lega Hoyte, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 21, 2021
Biologics in severe asthma: Which one, When and Where?Hitasha Rupani, Anna Murphy, Katie Bluer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 18, 2019
Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1Yanira Riffo-Vasquez, Varsha Kanabar, Sandra D Keir, et al.
Pageof 19